Abstract. This study investigated a role of decoy peptide region (R 10P IFLKRMPSI 19P ) in prorenin prosegment for prorenin binding to the (pro)renin receptor using the surface plasmon resonance technique. Three kinds of anti-receptor antibodies labeled as anti-107/121, anti-221/235 and anti-His tag antibody were prepared. The respective antigens D 107 SVANSIHSLFSEET 121 (close to the N-terminal side of receptor), E 221 IGKRYGEDSEQFRD 235 (N-terminal side of the transmembrane part of receptor) and 10xHis sequence (Cterminus) were designed based on the sequence of the receptor. These antibodies were immobilized on the CM5 sensor chip by amine coupling and allowed to bind to the receptor. Human prorenin, renin and the decoy bound to the receptor associated with antibodies. Their association (k a ) and dissociation (k d ) rate constants were measured and the dissociation constants (K D ) were determined using Langmuir 1:1 kinetic binding model. The K D for interaction of prorenin and receptor associated to anti-107/121, anti-221/235 and anti-His tag antibodies were 2.9, 1.2 and 7.8 nM, respectively and for renin they were 9.3, 4.4 and 7.1 nM. The decoy bound to the respective immobilized receptor-antibody complexes at K D 's of 6.2, 3.5 and 15.2 nM. Prorenin, renin and decoy had lower K D at the nanomolar ranges compared to those of L 1P PTD 4P in the prorenin prosegment and A 248 KKRLFDYVV 257 in the C-domain of mature renin. The decoy reduced the binding of not only prorenin but also renin to (P)RR. These data are direct evidence that prorenin, renin and the peptides bind to (P)RR and the decoy reduces prorenin binding, supporting our hypothesis that decoy peptide region has a crucial role in prorenin binding.
Introduction
The human (pro)renin receptor, h(P)RR, discovered and cloned by Nguyen et al (1) , binds renin then enhances its enzyme activity (1) (2) (3) . Moreover, prorenin bound to (pro)renin receptor [(P)RR] undergoes substantial increase in its renin activity without proteolytic cleavage of the amino terminal prosegment. Prorenin was found to bind to h(P)RR with a higher affinity than renin (1, 4) . (P)RR is expressed ubiquitously, particularly in renal glomeruli (1) , tubular systems (1), cardiac myocytes (3), including those in the cornea (5) and brain (6) . Thus, locally anchored activated prorenin on (P)RR and renin not only supply angiotensins to local tissues, they also stimulate the receptor to transmit its own signals which include phospho-extracellular signal-regulated kinase (ERK 1/2) (1,7), phospho-p38 mitogen-activated protein kinase (MAPK) (8) , profibrotic transforming growth factor (TGF)-ß1 (9) , and inflamatogenic cyclooxygenase-2 (COX-2) (10) which are involved in end-stage organ damage of kidney, heart, vasculature, retina, etc. These signal responses were observed not only in cultured cells stimulated by renin and prorenin, but also from end-stage damaged tissues such as diabetic kidneys and pressure-overloaded heart (9, 11, 12) . The degenerative effects of these signals seem to exert devastating effects, perhaps more severe than locally generated Ang II from immobilized renin and prorenin as attested by studies using mice lacking the Ang II type 1a receptor by Ichihara et al (13) .
Suzuki and associates discovered a short pentameric sequence near N-terminal region of the prosegment sequence of prorenin and named it 'handle region peptide' (HRP), which protrudes out of the surface of the prorenin molecule and readily binds to specific antibodies targeting this segment resulting in activation of prorenin (14) . This finding led Ichihara and his colleagues (15) to design a decameric decoy peptide by extending the C-terminus of HRP by 5 amino acid residues. This peptide has been found to inhibit the binding of renin/prorenin to the receptor as well as to block their receptor-mediated signal transduction in in vivo studies (2, 4, 6, 12, 13, (16) (17) (18) .
In diabetes, prorenin to renin ratio is markedly elevated in plasma. The elevated prorenin level has been considered as a cause of microvascular damage and microalbuminuria (19) (20) (21) . We found that chronic infusion of the decoy peptide effectively prevented the development of glomerulosclerosis and proteinuria for over a 28-week period (15, 16) .
A plausible mechanism of the therapeutic effects of the decoy peptide infusion may likely be due to the inhibition of prorenin-renin binding to (P)RR. For in vivo studies a specific inhibitor is a powerful tool for identifying a pathogenic mechanism of a disease as well as for developing a therapeutic strategy. However, direct evidence for the inhibition of prorenin-renin binding to the receptor by the decoy peptide has not been available. Without the solid mechanistic information, it is impossible to define the therapeutic mechanism of the decoy peptide. To shed light on the action of decoy peptide on prorenin-renin binding to the (P)RR we employed a novel approach for evaluating ligand binding to (P)RR by the surface plasmon resonance technique in BIAcore system which sensitively detects the binding of a ligand to a receptor immobilized onto antibodies coupled to the sensor chip. Here we report clear evidence for the high affinity binding of the decoy peptide with a dissociation constant (K D ) in a nanomolar range which makes it competitive enough against prorenin and renin binding whose K D 's are also at the level of nanomolar. Thus, we hypothesized that decoy peptide region in the N-terminal side of prosegment sequence of prorenin plays a crucial role in the binding of prorenin to (P)RR.
Materials and methods

Preparation of human renin, prorenin and (pro)renin receptor.
Chinese hamster ovary (CHO) cell lines harboring human prorenin cDNA were maintained (22) under humidified atmosphere of 5% CO 2 and 95% air in 25-cm 2 cell culture flasks (CELLSTAR, Greiner, Bio-One, Germany) until attaining 100% confluent monolayer in the DMEM medium with 10% fetal bovine serum by the method described earlier by Nabi et al (2) . A cDNA coding for human mature renin was inserted into the expression vector pcDNA3-sAgSP10xHis (2). The resulting plasmid was transfected into CHO cells to establish a permanent cell line by the method described previously (2) . The cell line secreted mature renin with a 10xHis tag into the culture medium. Recombinant prorenin with a 10xHis tag was prepared similarly. The media containing these preparations were collected and stored at -80˚C until further study.
A cDNA coding for the extracellular part of h(P)RR (N17-S304) with N-terminal FLAG tag (23) was inserted into the expression vector pcDNA3-sAgSP-10xHis. The extracellular part of h(P)RR with N-terminal FLAG tag and C-terminal deca histidine tag was transiently expressed in COS-7 cells and h(P)RR was purified by Ni Sepharose column chromatography.
Preparation of anti-receptor antibodies. Three antibodies against three epitopes of the 10xHis-tagged human (pro)renin receptor were used. The antigens D 107 SVANSIHSLFSEET
121
(close to the N-terminal side of the receptor), E 221 IGKRYGE DSEQFRD 235 (N-terminal side of the transmembrane part of the receptor) and 10xHis sequence (C-terminus) were designed based on the sequence of the receptor. The antibodies were named as anti-107/121, anti-221/235 and anti-His tag antibody, respectively. These were polyclonal antibodies, produced in rabbits and purified using affinity columns.
Immobilization of h(P)RR on the CM5 sensor chip using anti-receptor antibodies for real-time binding assay using BIAcore. BIAcore model 2000 (BIAcore AB, Uppsala, Sweden) was employed to study real-time binding of human renin and prorenin to h(P)RR which was immobilized to the CM5 sensor chip of the instrument at 25˚C. In the assay system the binding quantities of analytes can be observed in term of resonance units (RU). The response differences were calculated from the subtracted values of resonance units (RU) obtained from the specific and non-specific bindings of the analytes. The sensor chip in the flow cell of the instrument consisted of dextran matrix which contained carboxymethyl groups. This group was activated using N-ethyl-N 1 -dimethylaminopropyl carbodiimide (EDC) and N-hydroxysuccinimide (NHS) and was allowed to couple with amino groups of proteins of interest. However, directly coupled purified (P)RR did not show appreciable binding capacity to renin. 
Binding assay of renin, prorenin and decoy peptide to the h(P)RR associated with anti-receptor antibodies using
BIAcore. As described in the previous section a CM5 sensor chip affixed with immobilized h(P)RR via antibodies to the receptor epitopes were used in a BIAcore 2000. Renin and prorenin at concentrations of 0.1-2.0 nM as well as the decoy peptide (R 10P IFLKRMPSI 19P , including the 'handle region peptide') at concentrations of 20, 40, 80 and 100 nM were injected (flow rate: 10 μl/min) into the sensor chip for realtime kinetic study i.e., to determine their association (k a ) and dissociation rate constants (k d ) for the receptor from BIA evaluation method and their values of dissociation constant (K D ) were calculated from respective k a and k d values. In this case, flow cells within sensor chip containing immobilized anti-receptor antibodies lacking the h(P)RR were used as controls to determine the non-specific binding of renin, prorenin and the peptides. Also, different region peptides of prorenin and mature renin (L 1P PTD 4P , in the N-terminal side of prosegment and A 248 KKRLFDYVV 257 a sequence present in the C-domain, respectively) were tested in this study as reference peptides.
Interference of the binding of human renin and prorenin to the receptor by decoy peptide using BIAcore. Human prorenin or renin (0.5 nM) was co-incubated with decoy peptide (80 nM) to observe the inhibition of prorenin and renin binding to the immobilized receptor associated with different antibodies on CM5 sensor chip. The K D for receptor binding as well as association (k a ) and dissociation (k d ) rate constants were determined by BIA evaluation program. The resonance units (RU) are not proportional to the concentration of analytes rather than represent binding mass of renin, prorenin and the decoy peptide. Decrease of resonance units in the presence of the decoy peptide was caused by that lower mass of the peptide which excluded the binding of high molecular mass, renin and prorenin, to the receptor.
Results
Binding of h(P)RR to anti-receptor antibodies immobilized on
CM5 sensor chip. Concentration-dependent (using 6, 12, 24, 48 and 60 nM) binding of (P)RR to different antibodies immobilized to surfaces of the CM5 sensor chip were observed (data not shown). Fig. 1 shows typical binding of Fig. 2A and C show the sensogram developed from the interaction of soluble phase decoy peptide with the receptor associated with different anti-receptor antibodies. Fig. 2C shows the binding of decoy peptide at a concentration of 80 nM to h(P)RR associated with anti-107/121, anti-221/235 and anti-His tag antibodies. We determined the association (k a ) and dissociation (k d ) rate constants as well as its dissociation constant (K D ) for the interaction of decoy peptide with the receptor associated with these three antibodies using BIAevaluation Software. Data are summarized in Table I .
Binding assay of decoy peptide to h(P)RR associated with different antibodies.
Kinetic analysis of the decoy peptide binding to h(P)RR associated with anti-His tag antibody using BIAevaluation
software. Using the surfaces with immobilized anti-receptor antibodies, decoy peptide showed dose-dependent binding to the h(P)RR. Fig. 2A shows the typical dose-dependent binding of the peptide (20, 40, 80 and 100 nM) to h(P)RR associated with anti-His tag antibody. The sensograms for different concentrations of decoy peptide were analyzed using Langmuir 1:1 kinetic binding model by fitting both the association and dissociation phases simultaneously. Curves derived from these concentrations of decoy peptide exhibited good individual fits in the binding model and could be subjected to K D determination individually. The K D values determined were 9.3, 3.8, 15.2 and 6.1 nM, respectively. Reference peptides L 1P PTD 4P and A 248 KKRLFDYVV 257 showed very low RU even at a concentration of 100 nM (Fig. 2D) Table I . Kinetic parameters of decoy peptide binding to the receptor associated with anti-receptor antibodies immobilized to CM5 sensor chip.
Decoy peptide a binding to h(P)RR associated with antibodies
Anti-221/235 Anti-His tag  ---------------------------------------------------------------------------------------------------- 3.50x10 -9 ±0.3x10 -9
1.52x10 -8 ±0.7x10 -8 -
-----------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------
for a steady state binding between soluble phase of decoy peptide and immobilized receptor associated with antibody, equilibrium binding level was plotted vs. the concentration of the peptide (Fig. 2B) , and thus, replotted in double reciprocal plot. The steady state values at every different concentration were considered as the response at equilibrium (R eq ). These plots were developed from the response plateau values of the sensograms ( Fig. 2A) resultant of the interaction of peptide and immobilized receptor associated with antibody. The calculated K D was 12.5 nM.
Assay of renin and prorenin bindings to h(P)RR associated with anti-receptor antibodies.
Concentration-dependent bindings of prorenin and renin to (P)RR were observed in BIAcore assay system. The typical sensograms demonstrated in Fig. 3A and C were derived from the interaction of prorenin and renin with (P)RR while the receptor was associated with the immobilized anti-His tag antibody. The dissociation constants (K D ) for their steady state binding were 1.0 and 2.5 nM as described in the previous section and shown in Fig. 3B and D, respectively. Also, data summarized in Table  IIA 
Assay of interference of the bindings of renin and prorenin to h(P)RR associated with anti-receptor antibodies by decoy peptide.
When decoy peptide was co-incubated with renin or prorenin, the response signal for their binding to (P)RR associated with different anti-receptor antibodies on the sensor chip decreased to a lower level than that without peptide. Considering the K D values of the reference peptides, their effects on renin and prorenin binding to (P)RR was not performed. Fig. 4A and B show sensograms for the interference of the binding of prorenin and renin to (P)RR associated to anti-His tag antibody by the peptide, respectively.
Discussion
Although many studies have shown the effective blockade of prorenin activation by 'handle region peptide' (2, 13, 15, 18) , some incompatible results regarding the inhibitory effects of this peptide still persist (24) (25) (26) . These studies have used Table II . Kinetic parameters of the binding of human prorenin (A) and renin (B) to the receptor associated with anti-receptor antibodies immobilized to CM5 sensor chip.
Binding of prorenin a to h(P)RR associated with antibodies 1.2x10 -9 ±0.4x10 -9 7.8x10 -9 ±2.3x10 4.4x10 -9 ±1.7x10 -9 7.1x10 -9 ±2.9x10
; the data are indicated as mean ± SD (n=7). a Flow at 0.5 nM.
-
experimental approaches with different cell lines or animal models. Such in vivo studies could be influenced by some membrane associated proteins that might participate positively or negatively while observing the renin and prorenin activation, their (P)RR-mediated signalling pathways as well as blockade of their activation by HRP. To avoid such possibilities, intact form of highly purified renin, prorenin, peptides and (P)RR were used in vitro in surface plasmon resonance technique. Using this approach, we have tried to answer the following questions: a) does decoy peptide bind to (pro)renin receptor directly? b) if so then does it inhibit prorenin binding to the receptor? This study thus, demonstrated the direct binding of decoy peptide to the receptor, for the first time, using the surface plasmon resonance technique (BIAcore assay system) in vitro ( Fig. 2A and C and Table I ). Both renin and prorenin bound to the immobilized receptor and the decoy peptide inhibited renin and prorenin binding to the receptor (Fig. 3A and C, Fig. 4A and B and Table II) .
Kato et al (27) using BIAcore assay system reported binding of h(P)RR to the immobilized human renin on the surface of CM5 sensor chip. In these studies very high concentrations (in the range of μM) of h(P)RR was needed to observe binding to renin. At the same concentration, the h(P)RR did not bind immobilized prorenin. This might be due to the effects of amine coupling. To avoid such hazard in the present study on (P)RR binding we preferred to use biochemically intact renin, prorenin and h(P)RR preparations. Indeed, we observed very poor bindings of renin, prorenin and the peptide to the receptor when h(P)RR was directly coupled on the CM5 sensor chip by amine coupling as described in methods. Amine coupling required for their immobilization on the sensor chip might cause a change in conformation in those parts of molecules that are involved in the binding mechanism. To overcome this problem, anti-107/121, anti-221/235 and anti-His tag antibodies were used as connectors to intact h(P)RR to enable us to study interaction of intact renin, prorenin and receptor. Fortunately, antibodies were not affected by the amine coupling (Fig. 1) .
Human renin, prorenin and decoy peptide had different K D values for the receptor when associated with different antibodies (Tables I, IIA and B) . Furthermore, this study revealed that decoy peptide reduced the binding of renin and prorenin to the h(P)RR (Fig. 4A and B) . Highest amount of binding was observed within 60-70 sec when ligands were allowed to flow through the flow cells at a rate of 10 μl/min. Using independent t-test it was revealed that resonance signals of renin and prorenin binding to h(P)RR were reduced significantly when co-incubated with decoy peptide (p<0.001 in both cases, n=7). Here, data of the 60 sec were chosen arbitrarily for the comparison. On the other hand, peptides from other region of prorenin and mature renin bound to (P)RR (Fig. 2D ), but had >1000 times higher K D compare to that of the decoy peptide. Due to high values of K D , we did not perform the competitive binding study of prorenin and renin with these peptides. Also, we reported in our previous study that peptides from the prorenin prosegment region 7 P -10 P (termed as 'gate' region in ref. 14) and 30 P -36 P (close to the C-terminal end of prosegment) were unable to inhibit binding of prorenin to (P)RR expressed on the membrane of COS-7 cells (2). It was also found that prorenin had lower K D than renin for the (P)RR while associated with antibodies against the amino acid sequences 107-121 (K D values: 2.9 and 9.3 nM, respectively) and 221-235 (K D values: 1.2 and 4.4 nM, respectively). However, anti-His tag antibody associated receptor had K D values for renin and prorenin 7.1 and 7.8 nM, respectively obtained by Langmuir 1:1 kinetic binding model. The peptides of 10xHis tag was attached to the C-terminus of the receptor lacking the C-terminal transmembrane region in the intact (P)RR sequence. Therefore, association of h(P)RR with this antibody by the C-terminal 10xHis probably kept plenty of space for binding of renin and prorenin with their binding site(s) remaining unaffected.
The reason why prorenin has a lower K D for the receptor than renin (Table IIA and B) can be explained by the fact that the sequence of decoy peptide is present only in the prorenin molecule. On the other hand, we observed that the decoy peptide also inhibited the binding of renin (Fig. 4B) . In the Figure 4 . Binding of recombinant human prorenin (A) and renin (B) at 0.5 nM to h(P)RR associated with anti-His tag antibody on the surface of CM5 sensor chip using the surface plasmon resonance technique. Sensor chip containing immobilized anti-h(P)RR-antibody lacking the h(P)RR was used as control to determine non-specific bindings. Differences of resonance units were calculated by subtracting the resonance signal of non-specific binding from that of total binding. Decreased resonance unit in the presence of decoy peptide (80 nM) indicated interference of the binding of human renin and prorenin by the peptide, because the resonance unit represents the total binding mass of the analytes. The figure represents 7 identical experiments. present study, we determined the K D of the decoy peptide in the range of nanomolar by BIAcore assay system (Table I) . Moreover, the K D values of prorenin and renin to (P)RR were also in the range of nanomolar (Table IIA and B) . These data suggest that the decoy peptide competitively inhibits prorenin and renin binding to (P)RR. Such competitive inhibition has been estimated by other binding assay systems on the COS-7 cell membrane (2) . Therefore, the most probable explanation for the inhibition of renin binding could be the change in the conformation of h(P)RR due to binding of the decoy peptide. This might ultimately slowed down the access of renin to its binding site within the receptor. This study clearly demonstrates not only the inhibitory effects of decoy peptide but also its binding properties to the h(P)RR in vitro. Therefore, it supports our hypothesis that decoy peptide plays a crucial role in the binding of prorenin to human (pro)renin receptor. Nevertheless, though our in vitro study showed evidence of direct binding of the peptide to (P)RR and blockade of prorenin binding, it still remains to be clarified why in vivo studies are not compatible with each other.
